1. Identification of the Substance and of the Company
Name Used on Label: Gelest Titanium Dioxide SS ?WIA-SSA
INCI Name: Titanium Dioxides, Stearyl Triethoxysilane
Chemical Name: Titanium Dioxide, Octadecyltriethoxysilane
Company: GELEST, INC.
11 East Steel Road
Morrisville, PA 19067, USA
(215) 547-1015; e-mail: info@gelest.com
Emergency Telephone: CHEMTREC: US 800-424-9300 International: 703-527-3887
2. Hazards Identification
This product contains no substances classified as hazardous to health or environment.
May cause irritation to eyes.
HMIS Codes: Health: 0, Flammability: 0, Reactivity: 0
3. Composition / Information on Ingredients
Component CAS Number EC Number %
1 of 5 (WIA-SSA)
4. First Aid Measures
Eye Contact: Immediately flush eyes and under the eyelids with flowing water for at
least 15 minutes.
Skin Contact: Wash off with soap and plenty of water.
Inhalation: Move exposed individual to fresh air. Consult a physician after significant
exposure.
Ingestion: Do not induce vomiting. Drink water as a precaution. Consult a physician if
necessary.
5. Fire Fighting Measures
Fire and explosion hazards : No
Extinguishing media : None required
Fire fighting procedure : None required
6. Accidental Release Measures
Use any suitable mechanical means (vacuum, sweeping etc.). Avoid dust formation.
7. Handling and Storage
Storage: Keep in a clean and dry area in original unopened containers.
Handling: Avoid dust formation during handling. Provide appropriate exhaust ventilation
at places where dust can be generated. In case of insufficient ventilation, wear suitable
respiratory protection.
2 of 5 (WIA-SSA)
8. Exposure Controls / Personal Protection
OSHA PEL: 15mg/m3 (total); 5mg/m3 (Respirable)
ACGIH TLV: 10mg/m3 (total TWA); 5mg/m3 (Respirable)
Ventilation: Use adequate ventilation to maintain the concentrations below TLV.
Respiratory Protection: Avoid prolonged or intensive dust exposure; approved dust
respirators should be worn in locations where exposure limits may be exceeded.
Eye & Face Protection: If necessary, safety glasses or goggles should be worn in areas of
potentially high dust concentrations.
Hand Protection: Protective gloves generally are not required; but recommended for who
suffers from dermatitis or are susceptible to irritation and dry skin.
9. Physical and Chemical Properties
Appearance: White powder
Density: 3.9 g/cm3 Melting Point: >1800 oC
pH: NA Solubility in water: insoluble
10. Stability and Reactivity
This product is stable under the normal storage and handling conditions.
Decomposition products: No Hazardous products.
11. Toxicological Information
There is no data available for acute toxicity. Health injuries are not known or expected
under normal use.
12. Ecological Information
No known dangerous effects on the environment.
13. Disposal Considerations
This is not a hazardous waste; dispose of in accordance with local, state and federal
regulations. Dry material can be landfilled.
3 of 5 (WIA-SSA)
14. Transport Information
DOT Shipping Name: Not Regulated
DOT Hazard Class: None Required
DOT Label: None Required DOT ID No: None Required
15. Regulatory Information
Information on the warning label:
Symbol: none
Hazardous components which must be listed on the label:
R-phrase: none
Other information:
Titanium dioxide is listed on
AICS, DSL, MITI, TSCA
Not a hazardous substance or preparation according to EC directive 67/548/EEC or
1999/45/EC
The product does not need to be labeled in accordance with EC directives or respective
national laws.
16. Other Information
For research and industrial use only.
Training advice:
Read the safety data sheet before using the product.
Recommended restrictions: none
Further information: Carcinogenicity: In February 2006 IARC (International Agency for
Research on Cancer) concluded "there is inadequate evidence in humans for the
carcinogenicity of titanium dioxide". Based on rat inhalation studies, IARC concluded
that there is "sufficient evidence in experimental animals for the carcinogenicity of
titanium dioxide". IARC's overall evaluation was that "titanium dioxide is possibly
carcinogenic to humans (Group 2B)". This conclusion was based on IARC's guidelines
which require such a classification if two or more independent studies in one species
4 of 5 (WIA-SSA)
carried out at different times or in different laboratories or under different protocols show
evidence of tumors.
Additions, Deletions, Revisions 4/16/09: Revised INCI name in section 1.
This data sheet is prepared in accordance with European Community Directive 2001/58/EC, to the best
of our knowledge with current data available.
The information contained in this document has been gathered from reference materials and/or Gelest,
Inc. test data and is to the best knowledge and belief of Gelest, Inc. accurate and reliable. Such
information is offered solely for your consideration, investigation and verification. It is not suggested or
guaranteed that the hazard precautions or procedures described are the only ones which exist. Gelest,
Inc. makes no warranties, express or implied, with respect to the use of such information and assumes no
responsibility therefore. Information on this safety data sheet is not intended to constitute a basis for
product specifications.